Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 205.99 -2.93 (1.4%)
Previous Close $208.92    52 Week High $333.65 
Open $208.60    52 Week Low $223.02 
Day High $215.79    P/E 26.38 
Day Low $203.40    EPS $7.81 
Volume 1,124,201